| 101 |
9570926 | Bcl-xL modulates apoptosis induced by anticancer drugs and delays DEVDase and DNA fragmentation-promoting activities. | 1998 Apr 10 |
1 |
| 102 |
9576951 | Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases. | 1998 May 12 |
3 |
| 103 |
9642215 | Abrogation of mitochondrial cytochrome c release and caspase-3 activation in acquired multidrug resistance. | 1998 Jul 3 |
2 |
| 104 |
9790794 | Bcl-xL is expressed in ovarian carcinoma and modulates chemotherapy-induced apoptosis. | 1998 Sep |
1 |
| 105 |
9393748 | Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. | 1997 Dec 1 |
1 |
| 106 |
9494534 | Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression. | 1997 Nov-Dec |
1 |
| 107 |
14646525 | Role of apoptosis and apoptosis-related proteins in the cisplatin-resistant phenotype of human tumor cell lines. | 1997 |
2 |
| 108 |
8798452 | Bax can antagonize Bcl-XL during etoposide and cisplatin-induced cell death independently of its heterodimerization with Bcl-XL. | 1996 Sep 13 |
2 |
| 109 |
7655019 | Expression of bcl-xL can confer a multidrug resistance phenotype. | 1995 Sep 1 |
1 |